On June 18, Gelunhui announced that the board of directors of Wuxi Bio (02269.HK) granted a total of 434,227 restricted stock unit awards on June 18, 2024, but it needs to be accepted by the restricted stock unit award plan grantee according to the restricted stock unit award plan before it can take effect.
药明生物(02269.HK)授出合共43.4万股受限制股份
Wuxi Bio (02269.HK) granted a total of 434,000 restricted shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.